Literature DB >> 1102086

Current therapies in osteosarcoma.

H Handelsman, S K Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1102086     DOI： 10.1016/s0305-7372(75)80017-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.

Authors:  Yoshitaka Muramatsu; Takuya Matsui; Masataka Deie; Keiji Sato
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

2.  Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.

Authors:  Benjamin J Miller; Charles F Lynch; Joseph A Buckwalter
Journal:  Clin Orthop Relat Res       Date:  2013-07-03       Impact factor: 4.176

3.  Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.

Authors:  Jinna Wu; Huanhuan Sun; Jie Li; Yuanqing Guo; Kuibo Zhang; Chuandong Lang; Changye Zou; Haiqing Ma
Journal:  Cancer Med       Date:  2018-07-10       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.